Asaf Levi serves as the Chairman Of The Board and Director at NRGene Ltd., a genomic big data company that enhances the global breeding industry through advanced predictive computational methods, since 2016. In addition, Asaf is the Founder and CEO of Flow Group Ltd., a venture capital firm focused on investing in early-stage companies with transformative technologies, since 2012. Asaf also holds advisory roles, including Board Observer for Todos Technologies, Wisesight Technologies Ltd., and ViruCure Therapeutics, contributing expertise in developing innovative technologies across various sectors. Previously, Asaf was involved with Ayyeka, Jeeng Ltd., and Chakratec in director capacities, and worked as a Senior Investment Manager at Clal Insurance & Finance, overseeing significant client investments. Academic qualifications include a Bachelor of Business Administration in Economics and Business Management from The Open University of Israel.